1355041-02-9

Basic information

• Product Name: (1R,4R)-3-acetoxy-4-methylcyclohexanecarboxylic acid
• Synonyms: (1R,4R)-3-acetoxy-4-methylcyclohexanecarboxylic acid
• CAS NO: 1355041-02-9
• Molecular Weight: 200.235
• Mol File: 1355041-02-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1R,4R)-3-acetoxy-4-methylcyclohexanecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,4R)-3-acetoxy-4-methylcyclohexanecarboxylic acid(1355041-02-9)
• EPA Substance Registry System: (1R,4R)-3-acetoxy-4-methylcyclohexanecarboxylic acid(1355041-02-9)

Safety Data

• Hazardous Substances Data: 1355041-02-9(Hazardous Substances Data)

Upstream product

• 619-01-2 dihydrocarveol 
• 1355040-99-1 1-((1R,4R)-3-hydroxy-4-methylcyclohexyl)ethanone 
• 1355041-00-7 (1R,4R)-3-hydroxy-4-methylcyclohexanecarboxylic acid 
• 108-24-7 acetic anhydride 

Relevant articles and documents

COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS

A compound is represented by Structural Formula (I), or a pharmaceutically acceptable salt thereof, wherein the variables of Structural Formula (I) are as described in the specification and the claims. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier of excipient. A method of treating a HCV infection in a subject comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of inhibiting or reducing the activity of HCV polymerase in a subject or in a biological in vitro sample comprises administering to the subject or to the sample a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof.